Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Morepen Laboratories Limited
MOREPENLAB | NSE
37.20
INR3.52
10.45%
MOREPENLAB | NSE
Loading StockChartView...
About Morepen Laboratories Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
01/04/2026
Close
37.20
Open
34.56
High
37.40
Low
34.56
Morepen Laboratories Limited operates as a pharmaceutical and healthcare products company in India. The company manufactures active pharmaceutical ingredients (APIs) home diagnostics formulations and over the counter products. The company offers APIs for anti-histaminic anti-asthmatic anti-lipemic anti-hypertensive anti-diabetic drugs anti- coagulant anti-gout and anti- malarial drugs; and home diagnostic products such as air purifiers sphygmomanometer thermometers stethoscopes blood pressure monitors pulse-oximeters nebulizers glucometers blood glucose test strips and heat belt. It also provides Burnol first degree/minor burns cream; Fiber-X a sat isabgol; fever X for fever; Pain X for pain; Acidity X for acidity; and formulations for nutrition and probiotics gastroenterology antibiotics gynecology anti- allergic and central nervous system as well as cardiology diabetology and nutraceuticals. The company offers its over-the-counter products under the Dr. Morepen brand. It also exports its products. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram India.
View LessMOREPENLAB | NSE
Risk
61.8
Sharpe
-0.68
Luna's Score
55/100
Recommendation
Hold
Luna says (MOREPENLAB | NSE)
What's Working
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
82.0%1 month
61.8%3 months
59.8%6 months
45.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
37.53
Fwd. PE
-
Price to book
5.58
Debt to equity
0.03
Debt to assets
0.02
Ent. to EBITDA
27.45
Ent. to rev.
2.82
PEG
-
Other Fundamentals
EBITDA
1.81B
MarketCap
20.55B
MarketCap(USD)
220.51M
Div. yield
-
Op. margin
10.75
Erngs. growth
144.80
Rev. growth
13.70
Ret. on equity
12.08
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
6.25
Range1M
10.20
Range3M
15.79
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.52
Price X volume
207.21M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 27.45 | 24.85 | Par |
| Ent. to Revenue | 2.82 | 11.40 | Cheaper |
| PE Ratio | 37.53 | 51.36 | Cheaper |
| Price to Book | 5.58 | 6.83 | Par |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 59.76 | 42.17 | Riskier |
| Debt to Equity | 0.03 | 0.35 | Cheaper |
| Debt to Assets | 0.02 | 0.17 | Cheaper |
| Market Cap | 20.55B | 290.82B | Emerging |
